Acute respiratory distress syndrome

MA Matthay, RL Zemans, GA Zimmerman… - Nature reviews Disease …, 2019 - nature.com
The acute respiratory distress syndrome (ARDS) is a common cause of respiratory failure in
critically ill patients and is defined by the acute onset of noncardiogenic pulmonary oedema …

Regulation and repair of the alveolar-capillary barrier in acute lung injury

J Bhattacharya, MA Matthay - Annual review of physiology, 2013 - annualreviews.org
Considerable progress has been made in understanding the basic mechanisms that
regulate fluid and protein exchange across the endothelial and epithelial barriers of the lung …

Pulmonary alveolar type I cell population consists of two distinct subtypes that differ in cell fate

Y Wang, Z Tang, H Huang, J Li… - Proceedings of the …, 2018 - National Acad Sciences
Pulmonary alveolar type I (AT1) cells cover more than 95% of alveolar surface and are
essential for the air–blood barrier function of lungs. AT1 cells have been shown to retain …

Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management

MA Matthay, GA Zimmerman - American journal of respiratory cell …, 2005 - atsjournals.org
In 2005, the American Thoracic Society marks its 100th year of existence. For over a third of
this span, since 1967, clinicians and investigators have struggled with a common, often …

Lung epithelial fluid transport and the resolution of pulmonary edema

MA Matthay, HG Folkesson… - Physiological reviews, 2002 - journals.physiology.org
The discovery of mechanisms that regulate salt and water transport by the alveolar and
distal airway epithelium of the lung has generated new insights into the regulation of lung …

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury

T Uchida, M Shirasawa, LB Ware, K Kojima… - American journal of …, 2006 - atsjournals.org
Rationale: Receptor for advanced glycation end-products (RAGE) is one of the alveolar type
I cell–associated proteins in the lung. Objectives: To test the hypothesis that RAGE is a …

[HTML][HTML] In vitro and ex vivo models in inhalation biopharmaceutical research—advances, challenges and future perspectives

MA Selo, JA Sake, KJ Kim, C Ehrhardt - Advanced Drug Delivery Reviews, 2021 - Elsevier
Oral inhalation results in pulmonary drug targeting and thereby reduces systemic side
effects, making it the preferred means of drug delivery for the treatment of respiratory …

Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

CS Calfee, LB Ware, MD Eisner, PE Parsons… - Thorax, 2008 - thorax.bmj.com
Objectives: To determine whether baseline plasma levels of the receptor for advanced
glycation end products (RAGE), a novel marker of alveolar type I cell injury, are associated …

The development and plasticity of alveolar type 1 cells

J Yang, BJ Hernandez, D Martinez Alanis… - …, 2016 - journals.biologists.com
Alveolar type 1 (AT1) cells cover> 95% of the gas exchange surface and are extremely thin
to facilitate passive gas diffusion. The development of these highly specialized cells and its …

Ion transport by pulmonary epithelia

MI Hollenhorst, K Richter… - BioMed Research …, 2011 - Wiley Online Library
The lung surface of air‐breathing vertebrates is formed by a continuous epithelium that is
covered by a fluid layer. In the airways, this epithelium is largely pseudostratified consisting …